Subscribe to Marlin magazine and get a year of highly collectible, keepsake editions – plus access to the digital edition and archives. Sign up for the free Marlin email newsletter. On a breezy day in ...

Next year, Viking will introduce several new ocean and river itineraries, including winter season sailings in Northern Europe ...

CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase 3 trials for the subcutaneous formulation set to begin later in Q2 2025. Additionally, enrollment ...

Viking Therapeutics recently completed patient enrollment in its Phase 3 VANQUISH-2 trial of subcutaneous VK2735, a dual GLP-1/GIP agonist being evaluated over 78 weeks in about 1,000 adults with type ...

Viking will add a third ship to sail roundtrip voyages from the Maltese capital city of Valletta, a cultural UNESCO World Heritage Site. Malta also says it is the first European Union country to ...

Notes: 1) Observed values, no imputation for missing data. 2) Includes all participants who met the criteria for MetS at baseline and enough MetS component Week 13 data collected to determine MetS ...

Just call it history revisited. Viking is setting sail again in China. The Viking Yi Dun completed her first voyage from Shanghai to Hong Kong (Shenzhen). Viking’s new itineraries include a domestic ...

Results from VENTURE Phase 2 Study of Subcutaneous VK2735 in Obese Patients and Phase 1 Trial of Oral VK2735 in Healthy Subjects to be Presented SAN DIEGO, Oct. 28, 2024 /PRNewswire/ -- Viking ...

SAN DIEGO, June 25, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ...

Viking Mergers & Acquisitions had the honor of serving as a sponsor of the Rising Leaders Bestie Brunch at Predalina in Tampa ...